The initiators caspase-9 (CASP9) and caspase-10 (CASP10) are two key controllers of apoptosis and play important roles in carcinogenesis. This study aims to explore the association between CASPs gene polymorphisms and colorectal cancer (CRC) susceptibility in a population-based study. A two-stage designed population-based case-control study was carried out, including a testing set with 300 cases and 296 controls and a validation set with 206 cases and 845 controls. A total of eight tag selected single nucleotide polymorphisms (SNPs) in CASP9 and CASP10 were chosen based on HapMap and the National Center of Biotechnology Information (NCBI) datasets and genotyped by restriction fragment length polymorphism (RFLP) assay. Multivariate logistic regression models were applied to evaluate the association of SNPs with CRC risk. In the first stage, from eight tag SNPs, three polymorphisms rs4646077 (odds ratio (OR)AA+AG: 0.654, 95% confidence interval (CI): 0.406-1.055; P=0.082), rs4233532 (OR CC : 1.667, 95% CI: 0.967-2.876; OR CT : 1.435, 95% CI: 0.998-2.063; P=0.077), and rs2881930 (OR CC : 0.263, 95% CI: 0.095-0.728, P=0.036) showed possible association with CRC risk. However, none of the three SNPs, rs4646077 (OR AA+AG : 1.233, 95% CI: 0.903-1.683), rs4233532 (OR CC : 0.892, 95% CI: 0.640-1.243; OR CT : 1.134, 95% CI: 0.897-1.433), and rs2881930 (OR CC : 1.096, 95% CI: 0.620-1.938; OR CT : 1.009, 95% CI: 0.801-1.271), remained significant with CRC risk in the validation set, even after stratification for different tumor locations (colon or rectum). In addition, never tea drinking was associated with a significantly increased risk of CRC in testing set together with validation set (OR: 1.755, 95% CI: 1.319-2.334). Our results found that polymorphisms of CASP9 and CASP10 genes may not contribute to CRC risk in Chinese population and thereby the large-scale case-control studies might be in consideration. In addition, tea drinking was a protective factor for CRC.
Introduction
In the past few decades, the incidence of colorectal cancer (CRC) has increased drastically in many Asian countries, especially in China (Sung et al., 2005; Yee et al., 2010) . The Chinese National Office for Cancer Prevention and Control revealed that the large increase in the number of CRC cases (19.1% in men and 17.7% in women) was observed between 2000 and 2005 (Yang et al., 2005) . Environmental factors are thought to be related with risk of CRC, including lifestyle habits such as smoking, alcohol consumption, and tea consumption Huxley et al., 2009) . However, as a chronic complex disease, the genetic makeup of an individual might also contribute to CRC susceptibility .
Apoptosis is the process of programmed cell death (PCD), which mainly acts to develop and maintain tissue homeostasis in multicellular organisms (Grutter, 2000; Kumar, 2007) . Dysregulation of apoptosis has been found to increase the risk of many human disorders, including human malignancies (Hajra and Liu, 2004) . Caspases (CASPs) are a family of cysteine-dependent aspartate-specific proteases (Nicholson and Thornberry, 1997; Budihardjo et al., 1999) that play essential roles in apoptosis. The two distinct but converging pathways for CASP activation in human, the extrinsic or receptor-mediated pathway and the intrinsic or mitochondrial pathway, both own an independent group of initiator caspases (CASP8 and CASP10 for the extrinsic pathway, CASP9 for the intrinsic pathway). The initiator CASPs (Degterev et al., 2003; Wang et al., 2005) transmit death signals and further activate a cascade of effector CASPs (CASP3, CASP6, and CASP7), which result in final cell death by the process of proteolysis.
The genetic variants of CASP genes and cancer risk have been studied, covering various CASP genes and multiple cancers; however, the results have been inconsistent (Chen et al., 2008; Han et al., 2008; Ter-Minassian et al., 2008; Lan et al., 2009; Srivastava et al., 2010) . Nevertheless, the association between CASP polymorphisms and CRC risk has been reported in several studies. Liu B. et al. (2010) observed a marginally significant association of a 6-bp insertion/deletion polymorphism (−652 6N ins/del) of the CASP8 gene and an increased risk of rectum cancer (odds ratio (OR) del/del : 1.92, 95% confidence interval (CI): 0.97-3.79). Sun et al. (2007) identified the same variant, but with the opposite results of decreasing risk of colorectal cancer (OR del/del : 0.50, 95% CI: 0.31-0.79; OR ins/del : 0.80, 95% CI: 0.65-0.99). Haiman et al. (2008) and Pittman et al. (2008) performed case-control studies seeking to replicate Sun's finding. However, they did not find any statistically significant results. To our knowledge, no study has reported on the association of CASP9, CASP10 polymorphisms and risk of CRC thus far.
Due to complexity of finding low-penetrance risk allele in molecular epidemiological research, expansion of sample size and adjustment of all possible confounding factors are an effective way to promote the efficiency (Ulybina et al., 2009) . Nevertheless, it is difficult to collect big sample and identify all possible confounding factors. Therefore, alternative strategies and approaches of searching for polymorphic candidate SNPs are needed. In the present study, we have adopted a two-stage molecular epidemiological study, whereby DNA samples were divided into two parts according to the time when they collected. For the preliminary sorting, all the candidate SNPs were genotyped in the testing set, only those demonstrating possible association with CRC risk were further genotyped in the validation set. We hypothesized that CASP9 and CASP10 polymorphisms might affect the susceptibility of CRC. To test our hypothesis, eight tag SNPs in the two mentioned initiator CASP genes were selected and genotyped in a population-based case-control study.
Materials and methods

Study population
Recruitment of this population-based casecontrol study subjects had been previously reported (Fan et al., 2007; Zhang et al., 2009) . The study protocol was approved by the Institutional Review Board of Medical School of Zhejiang University, China. Briefly, this study included 506 histologically confirmed CRC patients from 2002 to 2008 and 1 141 controls without history of cancer randomly selected from the same population at the same time. In this study, a two-stage approach was utilized to compare single nucleotide polymorphism (SNP) frequencies (Thomas et al., 2004; Wang et al., 2006) . The DNA samples were separated into two parts. Subjects recruited between 2006 and 2008, containing 300 cases and 296 controls, were considered the testing set, while subjects recruited between 2002 and 2005, containing 206 cases as well as 845 controls, were categorized as the validation set. All study subjects were the Han Chinese residents.
After receiving written informed consent from each participant, a face-to-face interview was performed by well-trained investigators utilizing a structured questionnaire, consisting of demographic characteristics (age, sex, occupation, education level, etc.), lifestyle habits (smoking, alcohol drinking, tea drinking, etc.), family history of cancer, as well as the reproductive history of the female participants.
Lifestyle factors were determined as follows: subjects who had smoked at least once a day for more than one year were considered smokers; those who consumed alcohol or tea once a day for at least three months were defined as alcohol drinkers or tea drinkers, respectively. In addition, a 2-ml venous blood specimen was collected from each participant using a vacuum tube containing ethylene diamine tetraacetic acid (EDTA) and subsequently stored at −60 °C freezer until use.
DNA isolation, SNP selection, and genotyping
The genomic DNA was isolated from peripheral blood samples using modified salting-out extraction (Nasiri et al., 2005) , and the concentration as well as purity of DNA was measured by BioPhotometer (Eppendorf, Hamburg, Germany).
Selection of tag SNPs in CASP9 and CASP10 was based on the following criteria: at first, based on the National Center of Biotechnology Information (NCBI) SNP database and HapMap the Han Chinese population database, minor allele frequency (MAF) of SNPs more than 5% were picked up. Then, among selected SNPs, Haploview software was used for selecting tag SNP by implementing Paul de Bakker's Tagger tag SNP selection algorithm. Finally, a total of eight genetic polymorphisms were picked up ( Table 1 ).
The genotypes for CASP9 and CASP10 were detected by restriction fragment length polymorphism (RFLP) assay. The details of this approach has been described earlier (Liu C.Y. et al., 2010; Wu et al., 2011) . Information regarding sequences of the polymerase chain reaction (PCR) primer, restriction enzymes, PCR condition, as well as size of target PCR products is presented in Table 1 . Additionally, 10% of the random samples were genotyped repeatedly for quality control and concordance rate was 100%.
Statistical analysis
The distribution of socio-demographic variables between the case and control was analyzed by the Pearson χ 2 test for categorical variables and Student's t-test for continuous variables. The Hardy-Weinberg equilibrium in control subjects was assessed by a goodness-of-fit χ 2 test with one degree of freedom for all SNPs.
The associations of eight tag SNPs with CRC risk were assessed by multivariate unconditional logistic regression models, adjusted by potential confounding covariates, including sex (binary), age (continuous), body mass index (BMI) (binary), smoking (binary), alcohol drinking (binary), tea drinking (binary), and family history of cancer (binary). The ORs and Table 1 Basic information of SNPs
56.0 * After enzyme digestion; T m : melting temperature 95% CIs were calculated to assess the significance of potential at-risk genotypes. Furthermore, the potential gene-environment interactions were evaluated by stratified analysis. The likelihood ratio test comparing a model with and without the interaction terms was conducted to assess multiplicative interaction (Kleinbaum, 2002) . P≤0.1 was determined for statistical significance of the preliminary sorting, and the other statistical significance was assumed at P≤0.05. Every test was a two-side test. All of the statistical analyses were performed with statistical analysis system (SAS) software Version 9.1.3 (SAS Institute, Cary, NC).
Results
Characteristics of the study population
The distribution of demographics of the cases and controls in the testing set (with 300 cases and 296 controls) and validation set (with 206 cases and 845 controls) are presented in Table 2 . Our data showed that the distribution of age, sex, BMI, marital status, education level, family history of cancer, smoking status, alcohol drinking as well as tea drinking in both sets between the cases and controls was similar, with no significant difference. However, in the validation set, the control group owned a higher percentage of 
Association of lifestyle-related factors with CRC risk
When analyzed the adjusted association of lifestyle habits (smoking, alcohol drinking, and tea drinking) with CRC risk, we found that compared with the tea drinking group, the never tea drinking group showed a significantly increased risk of CRC in the testing set (OR: 1.603; 95% CI: 1.026-2.505) and overall subjects (testing set and validation set, OR: 1.755, 95% CI: 1.319-2.334). In validation set, only a marginally significant association was found (OR: 1.295; 95% CI: 0.858-1.955). No significant associations were revealed between smoking or alcohol drinking and CRC risk in any set.
Association of CASP gene with CRC risk
At the preliminary stage of the study, we used the tagging SNP approach for SNP sorting and selected nine tag SNPs in CASP9 and CASP10 genes for our study. However, we failed in analyzing one polymorphism (rs4661636) in spite of optimization primers and PCR conditions repeatedly, and the results were barely satisfactory. Subsequently, in the testing set, successful genotyping assays were developed for eight tag SNPs. The associations between the CASP9 and CASP10 gene polymorphisms with CRC risk are summarized in The validation set consisted of 206 cases and 845 controls. We did not consider this validation set alone but jointly analyzed the data from both the two sets as recommended by Skol et al. (2006) , which might increase power to detect genetic associations. However, for all the three SNPs, no significant statistical evidence of association with CRC risk was found, even after subgroup analysis for different tumor locations (Table 4) .
Furthermore, the wild-type G allele of rs4646077, the variant C allele of rs4233532, and the wild-type T allele of rs2881930 were considered as risk alleles. Both cases and controls were classified based on the individual number of risk alleles, and divided into three groups (number of risk alleles ≤1, =2, and ≥3). No significant results were observed even after a stratified analysis for tumor location (Table 5) .
Gene-environment interaction
Conducting likelihood ratio test was used to explore the multiplicative interaction between CASP9 and CASP10 polymorphisms and tea drinking (Table 6 ). For rs4646077, the significantly increased risk associated with GG or AA+AG genotype was apparent in the group of never tea drinking, with ORs of 1.832 (95% CI: 1.347-2.492) and 1.862 (95% CI: 1.168-2.969), respectively, compared with tea drinkers with the GG genotype. For rs4233532, never tea drinkers having CC+CT genotype significantly increased CRC risk, with an OR of 1.788 (95% CI: 1.245-2.568) compared with tea drinkers carrying the TT genotype. Additionally, for rs2881930, in the never tea drinking group, individuals carrying TT or CC+CT genotype were found to show an increased risk, the adjusted odds ratio being 1.695 (95% CI: 1.217-2.361) and 1.784 (95% CI: 1.246-2.555), respectively. Nevertheless, no significant multiplicative interaction was observed (P for interaction is 0.1559, 0.1255, and 0.7129, for rs4646077, rs4233532, and rs2881930, respectively). The interactions between CASP genotype and smoking or alcohol drinking on CRC risk were not statistically significant.
Discussion
In the present study, we investigated the association of CASP9 and CASP10 polymorphisms with CRC susceptibility in a two stage designed population-based case-control study in the Han Chinese population. However, no significant effects of eight tag SNPs involved in apoptosis genes on CRC predisposition were detected in our study. However, we found that tea drinking might be involved in reducing CRC risk.
Many studies (Kuzuhara et al., 2007; Hakim et al., 2008; Kawai et al., 2008) have demonstrated that tea drinking was a protective factor for CRC risk, consistent with our results. Our data suggested that no statistical significance for interaction between CASP9, CASP10 and tea drinking was detected, which was also consistent with previous studies. Zhang et al. (2005) found that never tea consumption increased risk of the non-cardiac gastric cancer with thymidylate synthase 3'-untranslated region (TS3'-UTR) 6-bp/6-bp genotype (OR: 3.19, 95% CI: 1.54-6.60). Wu et al. (2011) reported that never tea drinkers carrying xeroderma pigmentosum complementation group C (XPC) polymorphisms had a higher risk of CRC than tea drinkers. No significant interaction of TS3'-UTR or XPC polymorphism with tea drinking was found. Consequently, it was the positive effect of tea drinking itself mainly contributing to the association between Sun et al. (2007) identified that a 6-bp deletion (−652 6N del) variant in the CASP8 gene was associated with a decreased risk of multiple cancers, including CRC in a Chinese population. Haiman et al. (2008) and Pittman et al. (2008) conducted case-control studies in a Caucasian population with a relatively large sample size; however, no statistical significant results were observed in CRC (OR del/del : 1.08, 95% CI: 0.90-1.30; OR ins/del : 0.99, 95% CI: 0.86-1.14; and OR del/del : 0.99, 95% CI: 0.87-1.12; OR ins/del : 0.91, 95% CI: 0.81-1.01). In addition, our research group tested the same polymorphism in CASP8, and a Variant A allele of rs4646077, the variant C allele of rs4233532, and the variant C allele of rs2881930 were categorized as risk allele; b ORs were adjusted for age, sex, alcohol drinking, tea drinking, smoking, BMI, and family cancer history also did not find any significant association in a Chinese population (Liu C.Y. et al., 2010) .
It is plausible that CASP9 and CASP10, as the initiator CASPs, might confer cancer susceptibility based on the results of previous studies. Lan et al. (2006; and Hosgood et al. (2008; carried out a series of case-control studies looking at the association between CASP polymorphisms and the risk of blood system neoplasms, and reported that rs1052576 of CASP9 significantly decreased risk in both multiple myeloma (OR AG : 0.8, 95% CI: 0.5-1.3; OR AA : 0.5, 95% CI: 0.3-0.9) (Hosgood et al., 2008) and non-Hodgkin lymphoma (OR AG+AA : 0.6, 95% CI: 0.4-1.0) (Lan et al., 2006) , while CASP10 rs11674246 showed a marginally protective effect in chronic lymphocytic leukemia (OR TT : 0.74, 95% CI: 0.54-1.00) (Enjuanes et al., 2008) . Liu C.Y. et al. (2010) suggested that the genotype rs4661636 in CASP9 increased risk of esophageal adenocarcinoma (OR TT+CT : 3.52, 95% CI: 2.12-5.87). Li et al. (2008) and Frank et al. (2006) evaluated CASP10 rs13006529 polymorphism on the risk of cutaneous melanoma and familial breast cancer, with neither of the results reaching statistical significance. In the breast cancer, rs13010627 of CASP10 was found to be associated with a decreased risk (OR AA+AG : 0.62, 95% CI: 0.43-0.88) (Frank et al., 2006) ; however, this conclusion failed to remain significant in a subsequent large-scale pooled analysis (OR AA : 0.94, 95% CI: 0.72-1.22; OR AG : 1.03, 95% CI: 0.98-1.09) (Gaudet et al., 2009) . Oh et al. (2010) showed that CASP10 polymorphism increased the risk of CRC. Two CASP10 mutations were observed in 43 colon cancers (2/43, 4.3%) harboring additional CASP3, CASP7, and CASP8 mutations. In spite of low incidence, the data indicated that a CASP10 mutation might arouse the pathological changes of some colon carcinomas with other CASP gene mutations. Moreover, rs1052576, rs11674246, and rs13006529 detected above were in linkage disequilibrium with rs4646018 (r 2 =0.857 for rs1052576) and rs7576306 (r 2 =1.0 for rs11674246, r 2 =0.932 for rs13006529), which were genotyped in our study; however, we failed to find an association between any polymorphisms of the two SNPs in CASP9 and CASP10 with CRC risk.
There were some limitations in our populationbased case-control study. First, this study had insufficient power to detect very weak associations of CASP polymorphisms on CRC risk. Assuming the risk allele frequency ranged from 0.2 to 0.4, the power to detect an OR of 1.2 at a two-sided α=0.05 was less than 40% (from 28.8% to 39.2%). Second, because of the exhaustion of DNA samples, 26 cases (5.1%) and 79 (6.9%) controls were missed for rs4646077 in the joint analyses of both the testing set and validation set. However, these missing data displayed balanced distribution of demographic factors except tea drinking (tea drinkers 26.92% in cases vs. 50.63% in controls, P=0.03) (Table 7) , thus the negative influence on our result due to missing data may be reduced. Moreover, our research was not able to cover all the tag SNPs of CASP9 and CASP10 because one polymorphism (rs4661636) failed to be genotyped using current experimental technologies.
Conclusions
In conclusion, this study utilized a two-stage design for systematic analysis of association of tag SNPs in apoptotic genes CASP9 and CASP10 with CRC risk. Three candidate at-risk loci (rs4646077, rs2881930, and rs4233532) were identified in the testing set. However, in the joint analyses of both the testing set and validation set, these candidate genotypes showed no statistical significance. These findings should be confirmed in large-scale case-control studies. 
